Thanksgiving, plus a Fierce dessert

No doubt your plans for Thanksgiving vacation are being finalized as we publish our report today. This year, we're offering a variation on an old Fierce tradition. We'll be taking the traditional break for the holiday, but we're coming back on Friday with a special report outlining our most popular special features of the year. So sit back, enjoy the dinner and check back in Friday. I can just about guarantee you'll find something interesting. - John Carroll (email | twitter)

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.